<h1 id="kawasaki-disease">Kawasaki Disease</h1>
<p><strong>Definition:</strong> Acute, self-limited vasculitis of unknown etiology that occursmostly in infants and young children </p>
<p><strong>Classic clinical criteria</strong></p>
<ol>
<li><strong>Fever for ≥ 5 days</strong>, AND</li>
<li><p>At least <strong>4</strong> of the 5 following:</p>
</li>
<li><p>Bilateral bulbar nonexudative conjunctivitis</p>
</li>
<li>Cervical lymphadenopathy (&gt; 1.5 cm diameter), usually unilateral</li>
<li>Changes in lips and oral cavity<ul>
<li>Erythema</li>
<li>Lip cracking</li>
<li>Strawberry tongue</li>
<li>Diffuse injection of oral/pharyngeal mucosae</li>
</ul>
</li>
<li>Changes in extremities<ul>
<li>Acute: Erythema of palms or soles; edema of hands or feet</li>
<li>Subacute: Periungual peeling of fingers or toes in weeks #2-3&nbsp;</li>
</ul>
</li>
<li>Polymorphous rash</li>
</ol>
<p><img src="https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/5/m/053e3455-6dbd-5668-9861-6fe521dad8be/640.png" alt=""></p>
<h2 id="complications-and-differential-diagnosis">Complications and differential diagnosis</h2>
<p><strong>Complication:</strong> Coronary artery aneurysms/ ectasis --&gt; risk of MI,sudden death, ischemic heart disease (15-25% untreated, 5% if treated)</p>
<p><strong>Differential Diagnosis</strong></p>
<ul>
<li>Viral infections (measles, adenovirus, enterovirus, EBV)</li>
<li>Scarlet fever</li>
<li>Staphylococcal scalded skin syndrome</li>
<li>Toxic shock syndrome</li>
<li>Bacterial cervical lymphadenitis</li>
<li>Drug hypersensitivity reaction</li>
<li>Stevens-Johnson syndrome</li>
<li>Juvenile rheumatoid arthritis</li>
<li>Rocky Mountain Spotted Fever</li>
<li>Leptospirosis</li>
<li>Mercury hypersensitivity reaction </li>
</ul>
<h2 id="aha-2004-guideline-evaluation-of-suspected-incomplete-kawasaki-disease">AHA 2004 guideline: Evaluation of suspected incomplete Kawasaki Disease</h2>
<p><img src="https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/5/m/b55fbb14-0d75-5bf1-bb23-712f90bee994/640.png" alt=""></p>
<p><strong>AHA consensus recommendations</strong></p>
<ol>
<li>Infants ≤ 6 months old on day ≥ 7 of fever without other explanation should undergo lab testing and, if evidence of systemic inflammation is found, an echocardiogram, even if they have no clinical criteria</li>
<li>Check for classic findings</li>
<li>Supplemental lab criteria<ul>
<li>Albumin ≤3.0 g/dL</li>
<li>Anemia for age</li>
<li>Elevation of ALT</li>
<li>Platelets after 7 d ≥450,000/mm3</li>
<li>WBC ≥15,000/mm3,</li>
<li>Urine ≥10 WBC/hpf</li>
</ul>
</li>
<li>Can treat before performing echocardiogram.</li>
<li>Echo is considered positive for purposes of this algorithm, if any of 3 conditions met: <ul>
<li>z score of LAD or RCA ≥ 2.5</li>
<li>Coronary arteries meet Japanese Ministry of Health criteria for aneurysms, or </li>
<li>≥ 3 other suggestive features exist, including: perivascular brightness, lack of tapering, decreased LV function, mitral regurgitation, pericardial effusion, or z scores in LAD or RCA of 2–2.5</li>
</ul>
</li>
<li>If echo is positive, treatment should be given to children within 10 d of fever onset and those &gt; day 10 with clinical and lab signs (CRP, ESR) of ongoing inflammation</li>
<li>Typical peeling begins under nail bed of fingers and then toes</li>
</ol>
<h2 id="references">References</h2>
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15505111">Newburger JW et. al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.Circulation. 2004 Oct 26;110(17):2747-71.</a></li>
</ul>
